Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SDPA_Pet
    Senior Member
    • Apr 2013
    • 222

    #1

    Bbtools/BBmaps output questions

    Hello, I am using "stats.sh" command in BBtools to check my assembled metagenomes. I am looking for N50 and the largest contig. In my case, there is a line shows "Main genome contig N/L50: 7688/759" and "Max contig length: 5.905 KB". I know N50 and L50? What is N/L50 here? Does this mean N50 = 7688 and L50=759? Why my max contig length is shorter than N50? Is this possbile? (details see attached files)

    A C G T N IUPAC Other GC GC_stdev
    0.2126 0.2873 0.2874 0.2127 0.0000 0.0000 0.0000 0.5747 0.0976

    Main genome scaffold total: 19074
    Main genome contig total: 19074
    Main genome scaffold sequence total: 15.193 MB
    Main genome contig sequence total: 15.193 MB 0.000% gap
    Main genome scaffold N/L50: 7688/759
    Main genome contig N/L50: 7688/759
    Main genome scaffold N/L90: 16532/636
    Main genome contig N/L90: 16532/636
    Max scaffold length: 5.905 KB
    Max contig length: 5.905 KB
    Number of scaffolds > 50 KB: 0
    % main genome in scaffolds > 50 KB: 0.00%
    Attached Files
  • kmcarr
    Senior Member
    • May 2008
    • 1181

    #2
    Originally posted by SDPA_Pet View Post
    Does this mean N50 = 7688 and L50=759?
    Yes, that is what that means.
    Why my max contig length is shorter than N50? Is this possbile?
    Because Brian believes (and I agree with him, not that he requires any validation from me) the proper notation should be N50=number of contigs making 50% of your assembly and L50=length lower limit of contigs making up 50% of your assembly. So what stats.sh is telling you is that the largest 7,688 contigs account for 50% of your assembly length and those contigs are all ≥ 759bp.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...